The factors (IGFBP5, CLCF1 and IL6) reported to be secreted by CAFs indeed showed significantly higher expression in the high-risk group, suggesting that fibroblasts in the tumor microenvironment of LUAD likely contribute to the poor outcome in LUAD patients. The gene discussed is IGFBP5; the disease is neoplasm.